Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase
- PMID: 7505570
- DOI: 10.1006/bbrc.1993.2510
Effect of nitric oxide synthase substrate analog inhibitors on rat liver arginase
Abstract
Nitric oxide synthase (EC 1.14.23) substrate analog inhibitors NG-monomethyl-L-Arg, NG-nitro-L-Arg, NG-nitro-L-Arg methyl ester, and aminoguanidine were examined as potential inhibitors of rat liver arginase (EC 3.5.3.1). NG-nitro-L-Arg was found to inhibit arginase catalyzed conversion of L-Arg to L-Orn at pH 7.5 with an IC50 = 27.2 +/- 4.3 mM, compared to L-Val and L-Lys with IC50 values of 6.2 +/- 0.4 mM and 31.3 +/- 2.7 mM, respectively. Inhibition was stereospecific for the L-amino acid, not NG-nitro-D-Arg, and required a free alpha-carboxyl group. NG-nitro-L-Arg was not a substrate for rat liver arginase. These results suggest that arginase inhibition should also be evaluated when studying the effects of NOS substrate analog inhibitors in vivo.
Similar articles
-
Effects of NG-methyl-L-arginine, NG-nitro-L-arginine, and aminoguanidine on constitutive and inducible nitric oxide synthase in rat aorta.Biochem Biophys Res Commun. 1994 Feb 28;199(1):147-54. doi: 10.1006/bbrc.1994.1207. Biochem Biophys Res Commun. 1994. PMID: 7510104
-
Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.J Lab Clin Med. 1993 Oct;122(4):388-94. J Lab Clin Med. 1993. PMID: 7693839
-
Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors.J Pharmacol Exp Ther. 1995 Mar;272(3):1011-5. J Pharmacol Exp Ther. 1995. PMID: 7534350
-
Inhibition of nitric oxide synthase--potential for a novel class of therapeutic agent?Trends Biotechnol. 1995 Feb;13(2):70-8. doi: 10.1016/S0167-7799(00)88908-8. Trends Biotechnol. 1995. PMID: 7535060 Review.
-
Use of nitric oxide synthase inhibitors as a novel treatment for septic shock.Ann Pharmacother. 1995 Jan;29(1):36-46. doi: 10.1177/106002809502900108. Ann Pharmacother. 1995. PMID: 7536056 Review.
Cited by
-
Nf1 loss and Ras hyperactivation in oligodendrocytes induce NOS-driven defects in myelin and vasculature.Cell Rep. 2013 Sep 26;4(6):1197-212. doi: 10.1016/j.celrep.2013.08.011. Epub 2013 Sep 12. Cell Rep. 2013. PMID: 24035394 Free PMC article.
-
Expression of BDNF and TrkB Phosphorylation in the Rat Frontal Cortex During Morphine Withdrawal are NO Dependent.Cell Mol Neurobiol. 2016 Aug;36(6):839-849. doi: 10.1007/s10571-015-0267-6. Epub 2015 Sep 7. Cell Mol Neurobiol. 2016. PMID: 26346883 Free PMC article.
-
Loss of Nitric Oxide Induces Fibrogenic Response in Organotypic 3D Co-Culture of Mammary Epithelia and Fibroblasts-An Indicator for Breast Carcinogenesis.Cancers (Basel). 2021 Jun 5;13(11):2815. doi: 10.3390/cancers13112815. Cancers (Basel). 2021. PMID: 34198735 Free PMC article.
-
Known regulators of nitric oxide synthase and arginase are agonists at the human G-protein-coupled receptor GPRC6A.Br J Pharmacol. 2006 Apr;147(8):855-63. doi: 10.1038/sj.bjp.0706682. Br J Pharmacol. 2006. PMID: 16491104 Free PMC article.
-
Arginine metabolism: nitric oxide and beyond.Biochem J. 1998 Nov 15;336 ( Pt 1)(Pt 1):1-17. doi: 10.1042/bj3360001. Biochem J. 1998. PMID: 9806879 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials